[HTML][HTML] Genetic alterations in hepatocellular carcinoma: An update
ZS Niu, XJ Niu, WH Wang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Although recent advances in therapeutic approaches for treating HCC have …
worldwide. Although recent advances in therapeutic approaches for treating HCC have …
Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review
LN Fonseca, S Bolívar-Moná, T Agudelo, LD Beltrán… - Heliyon, 2023 - cell.com
Multipotent mesenchymal stromal cells (MSCs) have been described as bone marrow
stromal cells, which can form cartilage, bone or hematopoietic supportive stroma. In 2006 …
stromal cells, which can form cartilage, bone or hematopoietic supportive stroma. In 2006 …
MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells
A Eirin, SM Riester, XY Zhu, H Tang, JM Evans… - Gene, 2014 - Elsevier
Mesenchymal stromal/stem cells (MSCs) are clinically useful for cell-based therapy, but
concerns regarding their ability to replicate limit their human application. MSCs release …
concerns regarding their ability to replicate limit their human application. MSCs release …
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed
worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced …
worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced …
Curcumin suppresses doxorubicin-induced epithelial–mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast …
WC Chen, YA Lai, YC Lin, JW Ma… - Journal of agricultural …, 2013 - ACS Publications
Triple-negative breast cancer (TNBC) is defined by a lack of expression of the estrogen
receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER 2) …
receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER 2) …
[HTML][HTML] Molecular targeted therapy for hepatocellular carcinoma: current and future
JW Shin, YH Chung - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent tumors worldwide. The majority
of HCC cases occur in patients with chronic liver disease. Despite regular surveillance to …
of HCC cases occur in patients with chronic liver disease. Despite regular surveillance to …
Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy
Z Yin, K Jiang, R Li, C Dong, L Wang - Molecular Cancer, 2018 - Springer
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with high
morbidity, relapse and mortality rates. Multipotent mesenchymal stromal cells (MSCs) can be …
morbidity, relapse and mortality rates. Multipotent mesenchymal stromal cells (MSCs) can be …
Pharmacological modulation of beta‐catenin and its applications in cancer therapy
Abstract Beta‐catenin (β‐catenin) is a multifunction protein with a central role in
physiological homeostasis. Its abnormal expression leads to various diseases including …
physiological homeostasis. Its abnormal expression leads to various diseases including …
Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
YL Sha, S Liu, WW Yan, B Dong - Bioscience reports, 2019 - portlandpress.com
Hepatoblastoma is a malignant tumor in the liver of children that generally occurs at the age
of 2–3 years. There have been ample evidence from the preclinical as well as clinical …
of 2–3 years. There have been ample evidence from the preclinical as well as clinical …
Cysteine cathepsins: their biological and molecular significance in cancer stem cells
Cysteine cathepsins are lysosomal peptidases involved on one hand in general intracellular
protein degradation and, on the other, in the regulation of a number of specific physiological …
protein degradation and, on the other, in the regulation of a number of specific physiological …